320-47-8

Basic information

• Product Name: 4-NITRO-2-(TRIFLUOROMETHYL)BENZONITRILE
• Synonyms: 4-Nitro-2-trifluoromethylbenzotrile;4-Nitro-2-(Trifluoromethyl)Ben;2-Cyano-5-nitrobenzotrifluoride 98%;2-Cyano-5-nitrobenzotrifluoride98%;2-Cyano-5-nitrobenzotr;-Nitro-2-(trifluoromethyl)benzonitrile;2-Cyano-5-nitrobenzotrifluoride, 4-Cyano-3-(trifluoromethyl)nitrobenzene;4-Nitro-2-(trifluoromethyl)benzonitrile 98%
• CAS NO: 320-47-8
• Molecular Formula: C₈H₃F₃N₂O₂
• Molecular Weight: 216.12
• EINECS: -0
• Product Categories: Aromatic Nitriles;Nitrile;C8 to C9;Cyanides/Nitriles;Nitrogen Compounds
• Mol File: 320-47-8.mol

Chemical Properties

• Melting Point: 49-53 °C(lit.)
• Boiling Point: 297.7 °C at 760 mmHg
• Flash Point: >230 °F
• Appearance: white to light yellow crystal powder
• Density: 1.49 g/cm³
• Vapor Pressure: 0.00132mmHg at 25°C
• Refractive Index: 1.498
• Storage Temp.: Sealed in dry,Room Temperature
• BRN: 2281014
• CAS DataBase Reference: 4-NITRO-2-(TRIFLUOROMETHYL)BENZONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-NITRO-2-(TRIFLUOROMETHYL)BENZONITRILE(320-47-8)
• EPA Substance Registry System: 4-NITRO-2-(TRIFLUOROMETHYL)BENZONITRILE(320-47-8)

Safety Data

• Hazard Codes: Xi,T
• Statements: 36/37/38
• Safety Statements: 26-36
• RIDADR: 3276
• WGK Germany: 3
• HazardClass: 6.1
• PackingGroup: III
• Hazardous Substances Data: 320-47-8(Hazardous Substances Data)

Usage

Chemical Properties

white to light yellow crystal powder

InChI:InChI=1/C8H3F3N2O2/c9-8(10,11)7-3-6(13(14)15)2-1-5(7)4-12/h1-3H

Upstream product

• 367-67-9 2-bromo-5-nitro-benzotrifluoride 
• 544-92-3 copper(I) cyanide 
• 121-01-7 4-nitro-2-trifluoromethyl-aniline 
• 151-50-8 potassium cyanide 

Downstream Products

• 320-37-6 4-nitro-2-(trifluoromethyl)benzoic acid 
• 915779-75-8 4-dodecyloxy-2-trifluoromethylbenzonitrile 
• 393-06-6 4-amino-2-(trifluoromethyl)benzoic acid 
• 22227-54-9 4-nitro-2-trifluoromethylbenzamide 
• 1094279-18-1 4-octyloxy-2-trifluoromethylbenzonitrile 
• 1132110-15-6 4-decyloxy-2-trifluoromethylbenzonitrile 
• 1132110-16-7 4-tetradecyloxy-2-trifluoromethylbenzonitrile 
• 1132110-17-8 4-hexadecyloxy-2-trifluoromethylbenzonitrile 
• 50551-17-2 4-nitro-2-(trifluoromethyl)benzaldehyde 
• 1222257-58-0 C₁₈H₁₂F₃NO₅ 
• 654-70-6 4-amino-2-trifluoromethylbenzonitrile 
• 1417782-28-5 1-(4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl)ethan-1-one 
• 1096960-88-1 C₁₄H₇ClF₃NO 

Relevant articles and documents

Molecular self-assembly of macroporous parallelogrammatic pipes

The pipes, the pipes are calling: Organic parallelogram-shaped pipes of micrometer dimensions have been obtained by simply allowing drops of a solution of low-molecular-weight compounds to evaporate. This unique structure is formed by self-templated crystal growth during the evaporation. The mechanism of formation involves two polymorphic crystal forms in dynamic nonequilibrium conditions. (Figure Presented).

DIAMINE COMPOUND AND METHOD FOR PRODUCING SAME

The present invention provides a novel diamine compound capable of producing a polymer which exhibits greatly enhanced mechanical properties and heat resistance while maintaining transparency. A film including a polymer produced using the diamine compound has excellent transparency, heat resistance, mechanical strength and flexibility, and thus can be used in various fields, such as in a device substrate, a display cover substrate, an optical film, an Integrated circuit (IC) package, an adhesive film, a multi-layer flexible printed circuit (FPC), a tape, a touch panel and an optical disc protection film, and the like.

NOVEL CARBOXAMIDES, PRODUCTION AND USE THEREOF AS MEDICAMENTS

The invention relates to novel carboxamides of general formula (I), in which R1 to R5 are as defined in claim 1, the tautomers, enantiomers, diastereomers, mixtures and salts thereof, and the production and use thereof as medicaments. The compounds of the above general formula (I) have useful pharmacological effects, in particular an anti-thrombotic effect and a factor Xa inhibiting effect.

2,3-quinoxalinediones for use as neuroleptics

Heterocyclic dihydroxyquinoxaline compounds having the formula STR1 wherein R 1 is hydroxy, alkoxy, aryloxy, aralkyloxy, cycloalkylalkoxy, cycloalkoxy, or acyloxy; andR 5, R 6, R 7 and R 8 independently are hydrogen, NO 2, halogen CN, SO 2 NR''R'', SO 2 R'', CF 3, or OR'', wherein R'' is hydrogen or C 1-4 -alkyl;The invention also relates to a method of preparing the compounds, pharmaceutical compositions thereof, and their use.The compounds are useful in the treatment of indications caused by hyperactivity of the excitatory neurotransmitters, particularly the quisqualate receptors, and especially as neuroleptics.